Virology seminars
January 2023
Meningeal macrophages protect against viral neuroinfection
Rejane Rua· Aix Marseille Université, Inserm
Tue, Jan 17 · 06:00 UTC
https://doi.org/10.1016/j.immuni.2022.10.005
October 2021
Mutation induced infection waves in diseases like COVID-19
Fabian Jan Schwarzendahl· Heinrich Heine University, Dusseldorf
Mon, Oct 11 · 00:00 UTC
After more than 4 million deaths worldwide, the ongoing vaccination to conquer the COVID-19 disease is now competing with the emergence of increasingly contagious mutations, repeatedly supplanting earlier strains. Following the near-absence of historical examples of the long-time evolution of infectious diseases under similar circumstances, models are crucial to exemplify possible scenarios. Accordingly, in the present work we systematically generalize the popular susceptible-infected-recovered model to account for mutations leading to repeatedly occurring new strains, which we coarse grain based on tools from statistical mechanics to derive a model predicting the most likely outcomes. The model predicts that mutations can induce a super exponential growth of infection numbers at early times, which self-amplify to giant infection waves which are caused by a positive feedback loop between infection numbers and mutations and lead to a simultaneous infection of the majority of the population. At later stages -- if vaccination progresses too slowly -- mutations can interrupt an ongoing decrease of infection numbers and can cause infection revivals which occur as single waves or even as whole wave trains featuring alternative periods of decreasing and increasing infection numbers. Our results might be useful for discussions regarding the importance of a release of vaccine-patents to reduce the risk of mutation-induced infection revivals but also to coordinate the release of measures following a downwards trend of infection numbers.
July 2021
The Addgene AAV Data Hub was launched to help scientists share data and protocols obtained from AAV experiments. Our longterm goal is to provide scientists with a resource to help guide AAV selection and use by providing data from individual labs on AAV performance.
June 2021
Retroviruses and retrotransposons interacting with the 3D genome in mouse and human brain
Schahram Akbarian· Icahn School of Medicine at Mt. Sinai
Thu, Jun 17 · 15:00 UTC
Repeat-rich sequence blocks are considered major determinants for 3D folding and structural genome organization in the cell nucleus in all higher eukaryotes. Here, we discuss how megabase-scale chromatin domain and chromosomal compartment organization in adult mouse cerebral cortex is linked, in highly cell type-specific fashion, to multiple retrotransposon superfamilies which comprise the vast majority of mobile DNA elements in the murine genome. We show that neuronal megadomain architectures include an evolutionarily adaptive heterochromatic organization which, upon perturbation, unleashes proviruses from the Long Terminal Repeat (LTR) Endogenous Retrovirus family that exhibit strong tropism in mature neurons. Furthermore, we mapped, in the human brain, cell type-specific genomic integration patterns of the human pathogen and exogenous retrovirus, HIV, together with changes in genome organization and function of the HIV infected brain. Our work highlights the critical importance of chromosomal conformations and the ‘spatial genome’ for neuron- and glia-specific regulatory mechanisms and defenses aimed at exogenous and endogenous retrotransposons in the brain
April 2021
Mobilefuge: A low-cost, portable, open source, 3D-printed centrifuge that can be used for purification of saliva samples for SARS-CoV2 detection
Chinna Devarapu· Munster Technological University, Cork, Ireland and Tyndall National Institute, Cork, Ireland.
Fri, Apr 23 · 07:00 UTC
We made a low-cost centrifuge that can be useful for carrying out low-cost LAMP based detection of SARS-Cov2 virus in saliva. The 3D printed centrifuge (Mobilefuge) is portable, robust, stable, safe, easy to build and operate. The Mobilefuge doesn’t require soldering or programming skills and can be built without any specialised equipment, yet practical enough for high throughput use. More importantly, Mobilefuge can be powered from widely available USB ports, including mobile phones and associated power supplies. This allows the Mobilefuge to be used even in off-grid and resource limited settings. Website: https://www.cappa.ie/chinna-devarapu/
January 2021
RNA-driven phase separation from cells to SARS
Amy Gladfelter· UNC Chapel Hill
Fri, Jan 29 · 14:00 UTC
Biomolecular condensation is a mechanism for controlling cell organization. Many condensates are rich in nuclei acids such as RNA. The role of specific RNA sequences and structures in promoting the molecular identity of condensates formed for cell polarity and division and by the SARS CoV-2 virus will be discussed.
December 2020
Soft matter physics and the COVID-19 pandemic
William Poon· The University of Edinburgh
Wed, Dec 9 · 04:00 UTC
Much of the science underpinning the global response to the COVID-19 pandemic lies in the soft matter domain. Coronaviruses are composite particles with a core of nucleic acids complexed to proteins surrounded by a protein-studded lipid bilayer shell. A dominant route for transmission is via air-borne aerosols and droplets. Viral interaction with polymeric body fluids, particularly mucus, and cell membranes controls their infectivity, while their interaction with skin and artificial surfaces underpins cleaning and disinfection and the efficacy of masks and other personal protective equipment. The global response to COVID-19 has highlighted gaps in the soft matter knowledge base. I will survey these gaps, especially as pertaining to the transmission of the disease, and suggest questions that can (and need to) be tackled, both in response to COVID-19 and to better prepare for future viral pandemics.
2020 Nobel Prize Lectures in Physiology or Medicine
Harvey J. Alter, Michael Houghton, Charles M. Rice· National Institutes of Health, Bethesda, USA
Mon, Dec 7 · 12:00 UTC · Online
Harvey Alter, Michael Houghton and Charles Rice recount how an unexplained form of transfusion-associated hepatitis became an identifiable and treatable viral infection. Alter’s clinical and transmission studies distinguished non-A, non-B hepatitis from the known hepatitis viruses. Houghton’s molecular approach isolated genetic material from the elusive agent and enabled tests for hepatitis C infection. Rice’s experiments with viral RNA established that the newly identified virus could itself cause hepatitis and helped make its replication experimentally tractable. The lectures connect these complementary approaches to the development of safer blood supplies, experimental models and antiviral medicines, while showing how clinical observation, molecular cloning and causal experiments contributed different pieces of the discovery.
November 2020
Virus-like intercellular communication in the nervous system
Jason Shepherd· University of Utah
Tue, Nov 17 · 15:00 UTC
The neuronal gene Arc is essential for long-lasting information storage in the mammalian brain and mediates various forms of synaptic plasticity. We recently discovered that Arc self-assembles into virus-like capsids that encapsulate RNA. Endogenous Arc protein is released from neurons in extracellular vesicles that mediate the transfer of Arc mRNA into new target cells. Evolutionary analysis indicates that Arc is derived from a vertebrate lineage of Ty3/gypsy retrotransposons, which are also ancestral to retroviruses such as HIV. These findings suggest that Gag retroelements have been repurposed during evolution to mediate intercellular communication in the nervous system that may underlie cognition and memory.
October 2020
Lab-on-a-chip and diagnostic tools for COVID-19
Connie B. Chang· Montana State University
Wed, Oct 28 · 10:00 UTC
The SARS-CoV-2 virus has rapidly evolved into a pandemic that is threatening public health, economics, and quality of life worldwide. The gold-standard for testing individuals for COVID-19 is using traditional RT-qPCR, which is expensive and can take up to several hours. Expanding surveillance across a global scale will call for new strategies and tests that are inexpensive, require minimal reagents, decrease assay time, and allow for simple point-of-care (POC) monitoring without need of trained personnel and with quick turnaround time. To expand the speed of COVID-19 surveillance, we are working on a point-of-care microfluidic chip to enable significantly faster and easier testing. This is based upon digital drop loop-mediated isothermal amplification that will allow for rapid testing of large populations at a reasonable cost. The device will employ a nucleic-acid based test called reverse transcriptase LAMP (RT- LAMP) that operates at a temperature of 60-65°C. RT-LAMP removes the bottleneck of thermal cycling and high temperatures required by traditional RT-qPCR thermocycling. The simplicity, speed, and sensitivity will enable early treatment and response to infection.
End of results.